Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Cohen update 7/18/08

Nice Dutton has changed the price target to .092-1.21.

That looks better now come on TPL and Moore for answers to the patent rejections.

All the best,

Steve

Share
New Message
Please login to post a reply